4.6 Article

Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes

Journal

KIDNEY INTERNATIONAL REPORTS
Volume 6, Issue 8, Pages 2122-2133

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ekir.2021.05.014

Keywords

antibiotic; indoxyl sulfate; microbiome; p-cresyl sulfate; uremic toxins

Funding

  1. NYU CTSA grant from the National Center for the Advancement of Trans-lational Science (NCATS) [UL1TR000038]
  2. Oxalosis and Hyperoxaluria Foundation-American Society of Nephrology Career Development Award

Ask authors/readers for more resources

The study demonstrated that suppressing the microbiome with vancomycin led to changes in multiple gut-derived uremic solutes, but the recovery of solutes varied significantly among subjects.
Introduction: Declining renal function results in the accumulation of solutes normally excreted by healthy kidneys. Data suggest that some of the protein-bound solutes mediate accelerated cardiovascular disease. Many of the poorly dialyzable protein-bound uremic retention solutes are products of gut bacterial metabolism. Methods: We performed a blinded-randomized controlled trial comparing the changes in plasma concentrations of a panel of protein-bound solutes and microbiome structure in response to the once-weekly oral administration of 250 mg of vancomycin or placebo over a period of 12 weeks in a cohort of stable patients with end-stage kidney disease. We also examined the pattern of recovery of the solutes and gut microbiome over 12 weeks of placebo administration following vancomycin. Results: We enrolled 15 subjects. Ten subjects provided sufficient plasma and stool samples to permit us to examine the effect of vancomycin on plasma solute levels. We showed that a weekly dose of vancomycin resulted in a reduction in the plasma concentration of 7 colon-derived solutes. We described a significant effect of vancomycin on the microbiome structure with a decrease in alpha diversity and change in beta diversity. Multiple taxa decreased with vancomycin including genera Clostridium and Bacteroides. We demonstrated microbiome recovery after stopping vancomycin. However, recovery in the solutes was highly variable between subjects. Conclusions: We demonstrated that microbiome suppression using vancomycin resulted in changes in multiple gut-derived uremic solutes. Future studies are needed to address whether reduction in those uremic solutes results in improvement of cardiovascular outcomes in ESKD patients. (C) 2021 International Society of Nephrology. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available